Table 1.

Demographic features and laboratory values of the Crohn patients and controls.

	Control group(n: 36)	Activation ofCrohn’s (n: 37)	Remission ofCrohn’s (n: 28)	P-value
Age (years)	42.8 ± 11.53	42.4±13.1	47.1 ± 12.7	0.274
SexFemaleMale	26 (72.2%) 10 (27.8%)	24 (64.9%) 13 (35.1%)	11 (39.3%)17 (60.7%)	0.022
Hemoglobin (g/dL)	13.7 ± 1.3	12.9 ± 1.8	13.1 ± 1.7	0.120
Urea (mg/dL)	28.5 (10–50)	28 (10–52)	26 (8–79)	0.892
Creatinine (mg/dL)	0.8 (0.6–1.2)	0.9 (0.5–1.3)	0.9 (0.5–1.8)	0.051
ALT (IU/mL)	19 (8–40)	19 (12–66)	16 (10–56)	0.487
AST (IU/mL)	20 (10–59)	22 (10–46)	21 (15–34)	0.926
Albumin (mg/dL)	4.4 ± 0.2	4.3 ± 0.4	4.4 ± 0.3	0.679
Disease duration (years)	-	2 (0.4–11)	2.6 (0.6–4)	0.928
CDAI	-	177 (153–462)	49.5 (9–148)	<0.001
Localization of diseaseIlealColonicIleo-colonic		4 (10.8%)14 (37.8%)19 (51.4%)	10 (35.7%)8 (28.6%)10 (35.7%)

Data are presented as median (range) or mean ± SD.